News & Perspective

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Apr 20, 2016

Apr 20, 2016
Ebola virus

Trial suggests potential for sequential use of 2 Ebola vaccines

Meanwhile, a different study met with disappointing results for an experimental Ebola drug in the Sierra Leone trial.

Feb 25, 2016

Feb 25, 2016
Ebola survivor in Liberia

Studies on Ebola survivors show range of complications

Findings include neurologic problems and a potential for virus survival in semen for 18 months.